RAP-219 Clinical Trials
4 recruitingDrug
Phase 22Phase 32
Showing 1–4 of 4 trials
Recruiting
Phase 3
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
EpilepsyFocal EpilepsyFocal Seizure
Rapport Therapeutics Inc.333 enrolled3 locationsNCT07563881
Recruiting
Phase 3
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures
EpilepsyFocal EpilepsyFocal Seizure
Rapport Therapeutics Inc.312 enrolled2 locationsNCT07594119
Recruiting
Phase 2
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I Disorder
Bipolar 1 Disorder
Rapport Therapeutics Inc.250 enrolled22 locationsNCT07046494
Recruiting
Phase 2
A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures
seizureEpilepsyRefractory Focal Epilepsy+3 more
Rapport Therapeutics Inc.30 enrolled7 locationsNCT07219407